AlphaCrest Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-30,100
Closed -$154K 1419
2019
Q3
$154K Buy
30,100
+4,300
+17% +$22K 0.01% 1231
2019
Q2
$185K Buy
+25,800
New +$185K 0.02% 977